Silence Therapeutics plc / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €223.29M +220.8% -€69.75M +29.1% -31.2% +0.46 pp -€66.38M +16.2% -29.7% +0.52 pp
    (estimated) €69.61M +229.6% -€54.01M -15.7% -77.6% +2.3 pp -€57.15M -2.7% -82.1% +2.0 pp
    (estimated) €21.12M +46.6% -€64.06M -2.3% -303.3% +1.5 pp -€58.73M -33.4% -278.1% +3.3 pp
    (estimated) €14.41M -1.8% -€65.54M -3.9% -454.8% +0.10 pp -€88.21M +17.6% -612.1% -1.0 pp
    (estimated) €14.67M -60.6% -€68.23M +74.8% -465.1% -3.6 pp -€75.00M +29.1% -511.2% -3.6 pp
    €37.27M +27.5% -€39.04M -21.7% -104.7% +0.66 pp -€58.09M +28.3% -155.9% -0.0098 pp
    €29.24M +45.0% -€49.86M +6.9% -170.5% +0.61 pp -€45.29M -12.7% -154.9% +1.0 pp
    €20.17M +41.0% -€46.66M +2.7% -231.4% +0.86 pp -€51.87M -653.0% -257.2% -3.2 pp
    €14.31M +126.6% -€45.41M +21.1% -317.4% +2.8 pp €9.38M -179.3% 65.6% +2.5 pp
    €6.31M +2,145.5% -€37.51M +66.2% -594.0% +74 pp -€11.83M -691.1% -187.3% -9.0 pp
    €281.17K +∞% -€22.57M +6.4% -8,025.4% -80 pp €2.00M -110.5% 711.5% +7.1 pp
    €0.00 -100.0% -€21.22M +1,037.9% N/A -€19.10M +75.8% N/A
    €18.44K -97.9% -€1.86M -80.8% -10,112.5% -90 pp -€10.86M -1.1% -58,912.5% -580 pp
    €887.30K +∞% -€9.73M +27.0% -1,096.1% -11 pp -€10.98M +28.7% -1,237.5% -12 pp
    €0.00 -100.0% -€7.66M -40.1% N/A -€8.53M -18.8% N/A
    €17.29K -87.2% -€12.78M +23.2% -73,920.0% -660 pp -€10.51M +37.8% -60,800.0% -550 pp
    €134.82K -28.2% -€10.37M -65.8% -7,694.0% +84 pp -€7.63M +41.6% -5,656.4% -28 pp
    €187.83K -76.5% -€30.29M +358.1% -16,125.2% -150 pp -€5.39M -3.3% -2,867.5% -22 pp
    €799.72K -70.7% -€6.61M -34.8% -826.7% -4.5 pp -€5.57M -52.9% -696.7% -2.6 pp
    €2.73M +37.3% -€10.13M +17.7% -371.7% +0.62 pp -€11.82M +132.0% -433.6% -1.8 pp
    €1.99M -22.0% -€8.61M +0.5% -433.6% -0.97 pp -€5.10M -34.1% -256.7% +0.47 pp
    €2.55M -45.4% -€8.57M +45.6% -336.6% -2.1 pp -€7.73M +103.2% -303.7% -2.2 pp
    €4.66M +107.9% -€5.89M +33.5% -126.2% +0.70 pp -€3.81M -15.4% -81.6% +1.2 pp
    €2.24M +282.5% -€4.41M +6.7% -196.5% +5.1 pp -€4.50M +44.6% -200.4% +3.3 pp
    €586.54K +220.1% -€4.13M +21.3% -704.3% +12 pp -€3.11M +9.6% -530.1% +10 pp
    €183.22K -88.2% -€3.41M +29.6% -1,859.1% -17 pp -€2.84M +22.9% -1,548.4% -14 pp
    €1.55M +16.8% -€2.63M +53.7% -169.6% -0.41 pp -€2.31M +13.4% -149.1% +0.044 pp
    €1.33M +734.1% -€1.71M -32.4% -128.8% +15 pp -€2.04M -22.4% -153.5% +15 pp
    €159.02K -85.6% -€2.53M +12.9% -1,589.9% -14 pp -€2.62M -17.0% -1,650.0% -14 pp
    €1.11M -30.0% -€2.24M -9.2% -202.7% -0.47 pp -€3.16M +142.8% -286.1% -2.0 pp
    €1.58M +552.4% -€2.47M +35.5% -156.2% +6.0 pp -€1.30M -37.3% -82.5% +7.8 pp
    €241.99K +∞% -€1.82M -10.3% -751.9% -7.5 pp -€2.08M +19.2% -858.1% -8.6 pp
    €0.00 +NaN% -€2.03M +82.5% N/A -€1.74M +140.0% N/A
    €0.00 +NaN% -€1.11M +10.4% N/A -€725.97K -17.0% N/A
    €0.00 -€1.01M N/A -€874.63K N/A

    Notifications